Skip to main content

Peer Review reports

From: Intravenous immunoglobulin and rituximab versus placebo treatment of antibody-associated psychosis: study protocol of a randomised phase IIa double-blinded placebo-controlled trial (SINAPPS2)

Original Submission
7 Jan 2019 Submitted Original manuscript
25 Mar 2019 Author responded Author comments - Belinda Lennox
2 Feb 2019 Reviewed Reviewer Report - Stefano Comai
14 Feb 2019 Reviewed Reviewer Report - Silvia Cavedoni
Resubmission - Version 2
25 Mar 2019 Submitted Manuscript version 2
Publishing
28 Mar 2019 Editorially accepted
7 Jun 2019 Article published 10.1186/s13063-019-3336-1

You can find further information about peer review here.

Back to article page